FDA要求更新流感疫苗标签，注明发热性惊厥风险。
FDA requests flu vaccine label updates to include febrile seizure risk
生命科学资讯
生物技术与制药领域的最新动态
FDA要求礼来和诺和诺德移除GLP-1药物标签中的自杀风险警告。
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
安捷伦在生命科学、诊断及其他应用市场的宽阔护城河依然稳固——晨星
Agilent's Wide Moat Remains Intact in Its Life Science, Diagnostic, and Other Applied Markets - Morningstar
美国卫生与公众服务部在重组中撤换疫苗伤害小组成员。
HHS ousts vaccine injury panel members as reshaping takes hold
雅虎财经报道：制药业生产转移至美国，赛默飞世尔科技获新合同
Thermo Fisher wins contracts as pharma shifts production to US, CEO says - Yahoo Finance
赛默飞世尔科技CEO表示，随着制药业生产向美国转移，公司赢得合同——路透社
Thermo Fisher wins contracts as pharma shifts production to US, CEO says - Reuters
JPM26：Illumina推出十亿细胞图谱，推动AI驱动的药物研发 - 制药技术
JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery - Pharmaceutical Technology
特朗普政府似乎已结束对医药行业的美国贸易调查。
Trump administration appears to have ended its US trade probe into pharma
Illumina预计2025年收益增长达中双位数，逐步摆脱Grail收购案阴霾——晨星
Illumina Produces Midteens Earnings Growth in 2025, Distancing Itself From the Grail Debacle - Morningstar
2026年1月13日融资动态
Financings for Jan. 13, 2026
2026年1月13日门诊
In the clinic for Jan. 13, 2026
2026年1月13日其他值得关注的新闻
Other news to note for Jan. 13, 2026
2026年1月13日监管动态
Regulatory actions for Jan. 13, 2026
只剩一家：艾伯维达成最惠国定价协议
And then there was one: Abbvie reaches MFN pricing deal
奥瑞赛尔完成7000万美元C轮融资，推进国产CAR-T疗法发展。
Oricell raises $70M series C to advance China-developed CAR Ts
细胞/基因疗法行业步入可持续发展轨道；中国市场竞争日趋激烈
Cell/gene therapy sector now sustainable; China competition mounting
VantAI获8000万美元融资并更名；Dynavax披露在赛诺菲之前曾有潜在收购方。
VantAI gets $80M and new name; Dynavax discloses it had pre-Sanofi suitor
赛默飞世尔科技推出新型智能拉曼+光谱仪 - 合同制药
Thermo Fisher Scientific Launches New SmartRaman+ Spectrometer - Contract Pharma
赛默飞世尔科技推出新型高端手持式XRF分析仪，扩展现场应用光谱产品线。
Thermo Fisher Expands Handheld XRF Line with New High-End Analyzer for Field Use - Spectroscopy Online
Saga Diagnostics扩展超灵敏血液检测，涵盖结直肠癌筛查
Saga Diagnostics expands ultrasensitive blood test to include colorectal cancer